Risk factors in the early diagnosis of ALS: North American epidemiological studies

Amyotrophic Lateral Sclerosis

Volumn 1, Issue SUPPL. 1, 2000, Pages

  Brooks, Rix Benjamin ^a  

^a University of Wisconsin Health   (United States)

Author keywords

diagnosis; motor neuron disease; outcome measure; patient registry; population based

Indexed keywords

ARTICLE; CASE CONTROL STUDY; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; CULTURAL FACTOR; HEALTH SURVEY; HUMAN; INCIDENCE; MOTOR NEURON DISEASE; NORTH AMERICA; OCCUPATIONAL EXPOSURE; RISK FACTOR;

CASE-CONTROL STUDIES; CROSS-CULTURAL COMPARISON; CROSS-SECTIONAL STUDIES; HUMANS; INCIDENCE; MOTOR NEURON DISEASE; NORTH AMERICA; OCCUPATIONAL EXPOSURE; POPULATION SURVEILLANCE; RISK FACTORS;

EID: 0038522367     PISSN: 17482968     EISSN: 1471180X     Source Type: Journal    
DOI: 10.1080/14660820052415871     Document Type: Article

References (31)

1. Gaziano JM, Sesso HD, Breslow JL, Hennekens CH, Buring JE. Relation between systemic hypertension and blood lipids on the risk of myocardial infarction. Am J Cardiol 1999; 84: 768-773.
2. Whisnant JP, Brown RD, Petty GW, O'Fallon WM, Sicks JD, Wiebers DO. Comparison of population-based models of risk factors for TIA and ischemic stroke. Neurology 1999; 53: 532-536.
3. Chiò A. Risk factors in the early diagnosis of ALS: European epidemiological studies. ALS 2000; 1 (Suppl 1): S13-S18.
4. Kaplan GA, Haan MN. Wallace RB. Understanding changing risk factor associations with increasing age in adults. Ann Rev Public Health 1999; 20: 89-108.
5. Brooks BR. Clinical epidemiology of amyotrophic lateral sclerosis. Neurol Clin 1996; 14: 399-420.
6. Preux PM, Couratier P, Boutros-Toni F et al. Survival prediction in sporadic amyotrophic lateral sclerosis. Age and clinical form at onset are independent risk factors. Neuroepidemiology 1996; 15: 153-160.
7. Ringel SP, Murphy JR, Alderson MK et al. The natural historyof amyotrophic lateral sclerosis. Neurology 1993; 43: 1316-1322.
8. Haverkamp LJ, Appel V, Appel SH. Natural history of amyotrophic lateral sclerosis in a database population. Validation of a scoring system and a model for survival prediction. Brain 1995; 118(Pt 3): 707-719.
9. Brooks BR. Natural history of ALS: symptoms, strength, pulmonary function, and disability. Neurology 1996; 47(4 Suppl 2): S71-S81; discussion S81-S82.
10. Armon C, Moses D. Linear estimates of rates of disease progression as predictors of survival in patients with ALS entering clinical trials. J Neurol Sci 1998; 160 (Suppl 1): S37-S41.
11. Stambler N, Charatan M, Cedarbaum JM. Prognostic indicators of survival in ALS. ALS CNTF Treatment Study Group. Neurology 1998; 50: 66-72.
12. Anderson FA Jr, Miller RG. ALS CARE: a resource for measuring and improving ALS outcomes. Neurology 1996; 47 (4 Suppl 2): S113-S115; discussion S115-S116.
13. Jenkinson C, Swash M, Fitzpatrick R. The European Amyotrophic Lateral Sclerosis Health Pro.le Study. ALS-HPS Steering Group. J Neurol Sci 1998; 160 (Suppl 1): S122-S126.
14. Annegers JF, Appel S, Lee JR, Perkins P. Incidence and prevalence of amyotrophic lateral sclerosis in Harris County, Texas, 1985-1988. Arch Neurol 1991; 48: 589-593.
15. Yoshida S, Mulder DW, Kurland LT, Chu CP, Okazaki H. Follow-up study on amyotrophic lateral sclerosis in Rochester, Minn., 1925 through 1984. Neuroepidemiology 1986; 5: 61-70.
16. McGuire V, Longstreth WT Jr, Koepsell TD, van Belle G. Incidence of amyotrophic lateral sclerosis in three counties in western Washington state. Neurology 1996; 47: 571-573.
17. Taylor JA, Davis JP. Evidence for clustering of amyotrophic lateral sclerosis in Wisconsin. J Clin Epidemiol 1989; 42: 569-575.
18. Sienko DG, Davis JP, Taylor JA, Brooks BR. Amyotrophic lateral sclerosis. A case-control study following detection of a cluster in a small Wisconsin community. Arch Neurol 1990; 47: 38-41.
19. Armon C, Kurland LT, Daube JR, O'Brien PC. Epidemiologic correlates of sporadic amyotrophic lateral sclerosis. Neurology 1991; 1: 1077-1084.
20. Cruz DC, Nelson LM, McGuire V, Longstreth WT Jr. Physical trauma and family history of neurodegenerative diseases in amyotrophic lateral sclerosis: a population-based casecontrol study. Neuroepidemiology 1999; 18: 101-110.
21. Longstreth WT, McGuire V, Koepsell TD, Wang Y, van Belle G. Risk of amyotrophic lateral sclerosis and history of physical activity: a population-based case-control study. Arch Neurol 1998; 55: 201-206.
22. McGuire V, Longstreth WT Jr, Nelson LM et al. Occupational exposures and amyotrophic lateral sclerosis. A populationbased case-control study. Am J Epidemiol 1997; 145: 1076-1088.
23. Deapen DM, Henderson BE. A case-control study of amyotrophic lateral sclerosis. Am J Epidemiol 1986; 123: 790-799.
24. Johansen C, Olsen JH. Mortality from amyotrophic lateral sclerosis, other chronic disorders, and electric shocks among utility workers. Am J Epidemiol 1998; 148: 362-368.
25. Nelson LM. Epidemiology of ALS. Clin Neurosci 1995-96; 3: 327-331.
26. Savitz DA, Loomis DP, Tse CK. Electrical occupations and neurodegenerative disease: analysis of U.S. mortality data. Arch Environ Health 1998; 53: 71-74.
27. Savitz DA, Checkoway H, Loomis DP. Magnetic .eld exposure and neurodegenerative disease mortality among electric utility workers. Epidemiology 1998; 9: 398-404.
28. Nicholas JS, Lackland DT, Dosemeci M et al. Mortality among US commercial pilots and navigators. J Occup Environ Med 1998; 40: 980-985.
29. Lee JR, Annegers JF, Appel SH. Prognosis of amyotrophic lateral sclerosis and the effect of referral selection. J Neurol Sci 1995; 132: 207-215.
30. Brooks BR. El Escorial World Federation of Neurology criteria for the diagnosis of amyotrophic lateral sclerosis. Subcommittee on Motor Neuron Diseases/Amyotrophic Lateral Sclerosis of the World Federation of Neurology Research Group on Neuromuscular Diseases and the El Escorial 'Clinical limits of amyotrophic lateral sclerosis' workshop contributors. J Neurol Sci 1994; 124 (Suppl): 96-107.
31. Lilienfeld DE, Perl DP. Projected neurodegenerative disease mortality in the United States, 1990-2040. Neuroepidemiology 1994; 13: 179-186.